Poor R-Wave Progression and Long-Term Outcomes in the Multi-Ethnic Study of Atherosclerosis (MESA)
de Alencar, J. N.; Felicioni, S. P.; Marchi, M. F. N. D.
Show abstract
BackgroundPoor R-wave progression (PRWP) on the 12-lead electrocardiogram has been linked to adverse outcomes. Its prognostic value in a contemporary, multi-ethnic population without baseline coronary artery disease (CAD) is unclear. MethodsWe analyzed 6,323 adults (mean age 61.9{+/-}10.2 years; 54% women) from the Multi-Ethnic Study of Atherosclerosis after excluding pre-excitation, major conduction disease, Q-wave infarction, and missing covariates. PRWP was defined as R-wave amplitude [≤]3 mm in V3 with RV3>RV2 and was present in 202 participants (3.2%). Outcomes were all-cause mortality, cardiovascular (CV) death, and major adverse cardiovascular events (MACE: nonfatal myocardial infarction, resuscitated cardiac arrest, or stroke). Cox models adjusted for age, sex, race/ethnicity, hypertension, and diabetes. ResultsOver a median 14.1 years (IQR, 13.5-14.7), 1,138 deaths, 256 CV deaths, and 515 MACE occurred. Among PRWP participants, there were 52 deaths (25.7%), 8 CV deaths (4.0%), and 16 MACE (7.9%). In prespecified models, PRWP was not associated with CV death (hazard ratio [HR] 0.87; 95% CI, 0.43-1.76; P=0.690) or MACE (HR 0.94; 95% CI, 0.57-1.54; P=0.796) and showed a borderline association with all-cause mortality (HR 1.31; 95% CI, 0.99-1.73; P=0.059), driven by non-CV deaths. Adjustment for smoking and emphysema attenuated estimates (all-cause HR 1.19; 95% CI, 0.90-1.58; P=0.229). A PRWPxsex interaction was significant for MACE (likelihood-ratio test P=0.002), driven by higher stroke incidence in women; interactions by race/ethnicity were not significant. ConclusionsIn a large, CAD-free, multi-ethnic cohort, isolated PRWP was uncommon and did not confer independent risk for CV death or MACE over 14 years. The borderline excess in all-cause mortality was non-CV and diminished after accounting for smoking and emphysema.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Genetically Predicted IL-18 Inhibition and Risk of Cardiovascular Events: A Mendelian Randomization Study 94%
- CD206 + IL-4Rα + MACROPHAGES ARE DRIVERS OF ADVERSE CARDIAC REMODELING IN ISCHEMIC CARDIOMYOPATHY 93%
- Aptamer Proteomics for Biomarker Discovery in Heart Failure with Reduced Ejection Fraction 93%
Similar papers in this journal
- Cardiac impairment in Long Covid 1-year post-SARS-CoV-2 infection 93%
- Clinical presentation, disease course and outcome of COVID-19 in hospitalized patients with and without pre-existing cardiac disease – a cohort study across sixteen countries 92%
- Endocardial/endothelial angiocrines regulate cardiomyocyte development and maturation and induce features of ventricular non-compaction 91%
Similar papers in this journal
- Clinical and genetic associations of asymmetric apical and septal left ventricular hypertrophy 95%
- Development and Multinational Validation of an Ensemble Deep Learning Algorithm for Detecting and Predicting Structural Heart Disease Using Noisy Single-lead Electrocardiograms 94%
- Natural Language Processing to Identify Racial and Ethnic Disparities in Aortic Stenosis 92%
Similar papers in this journal
- Development and validation of imaging-free myocardial fibrosis prediction models, association with outcomes, and sample size estimation for phase 3 trials 93%
- Mineralocorticoid Receptor Antagonism Reduces Atrial Arrhythmias Post-Cardiac Surgery and Attenuates Atrial Stress Responses to Cardioplegic Arrest 92%
- Causes of death in people with cardiovascular disease: a prospective UK Biobank cohort study 91%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.